We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Resolves Warning Letter, Awaits FDA Approval of Supplements
Merck Resolves Warning Letter, Awaits FDA Approval of Supplements
August 1, 2008
Merck has resolved a warning letter citing GMP violations at its vaccine operations in West Point, Pa., and resolved supply constraints for bulk varicella, which had affected the sale of certain vaccines.